Prognosis of Henoch-Sch(o)nlein Purpura Nephritis in the Past Decade

GUO Gui-mei,HE Wei-xun,ZHU Guang-hua

DOI: https://doi.org/10.3969/j.issn.1000-3606.2011.04.006

2011-01-01

Abstract:Objective To evaluate the prognosis of children with Henoch-Schnlein purpura nephritis(HSPN)in the past decade,from 1999 to 2008,and to analysis the possible influence effactors.Methods A total of 101 HSPN patients with renal biopsy were followed up.Kaplan-Meier analysis and the Logrank test were applied to study the renal remission.Meanwhile,the diagnosis and management of HSPN were evaluated.Results According to period,there were 39 patients in the first five years(from 1999 to 2003,early group),and 62 patients in the second five years(from 2004 to 2008,late group)respectively.There were no significant differences in sex,age and extrarenal manifestations between early and late group.The mean elapsed time between abnormal urine routine examination to acceptance of renal biopsy was significantly shorter in later group(6.63 ± 1.24 months)than that in early group(13.47 ± 3.08 months)(P 0.05).Compared the treatment between two groups,in early group,there were more patients having therapy with intravenous cyclophosphamide(30.8% vs.9.7%,P 0.01);and less patients having therapy with new immunosuppressive agents mycophenolate mofetil(MMF)and ACE inhibitor plus angiotensin receptor blocker(ACEI/ARB)(10.3% vs.30.6%,and 51.3% vs.74.2%,all P 0.05).In early group,the patients had more severity and extent of renal lesion than that in late group(41.0% vs.22.6%).The recovery of renal function was better in late group than that in early group(χ2 = 4.709,P 0.05).Conclusions The prognosis of pediatric HSPN patients was significantly improved from 1999 to 2008,which might be attributed to earlier renal biopsy,rational treatment strategies,e.g.MMF and ACEI/ARB.